Assessment of cell-binding capacity of shed rAAV particles after gene therapy vector administration: implications for environmental risk and hygiene recommendations
The lower binding capacity of the shed vector particles speaks in favor of a more relaxed containment and hygiene approach in the context of GT. It is recommended that current hygiene and contact-avoidance-based containment measures after GT administration are reduced. The results also support the efforts to achieve a simplification of the regulatory review process of medicinal genetically modified organisms.
Authors
- Tobias Fleischmann (ORCID: https://orcid.org/0000-0001-8171-6841)
Institutions
- Pfizer (Germany) (DE)
Publication Details
- Journal
- Expert Opinion on Biological Therapy
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1080/14712598.2024.2418961
- Primary Topic
- Virus-based gene therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer